ATE553129T1 - Antikörper gegen humanes il-12 - Google Patents

Antikörper gegen humanes il-12

Info

Publication number: ATE553129T1
Authority: AT; Austria
Prior art keywords: antibodies; human
Prior art date: 1998-01-23

Application number

AT07005606T

Other languages

English (en)

Inventor

Maurcie Kent Gately

David Howard Presky

Original Assignee

Hoffmann La Roche

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-01-23

Filing date

1999-01-15

Publication date

2012-04-15

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22106938&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE553129(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1999-01-15 Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche

2012-04-15 Application granted granted Critical

2012-04-15 Publication of ATE553129T1 publication Critical patent/ATE553129T1/de

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/24—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
- C07K16/244—Interleukins [IL]
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/24—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
- C07K2317/73—Inducing cell death, e.g. apoptosis, necrosis or inhibition of cell proliferation
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
- C07K2317/76—Antagonist effect on antigen, e.g. neutralization or inhibition of binding

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Immunology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Diabetes (AREA)
Genetics & Genomics (AREA)
Biophysics (AREA)
Biochemistry (AREA)
Molecular Biology (AREA)
Rheumatology (AREA)
Emergency Medicine (AREA)
Obesity (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Pain & Pain Management (AREA)
Physical Education & Sports Medicine (AREA)
Orthopedic Medicine & Surgery (AREA)
Endocrinology (AREA)
Hematology (AREA)
Biomedical Technology (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Transplantation (AREA)
Peptides Or Proteins (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)

AT07005606T 1998-01-23 1999-01-15 Antikörper gegen humanes il-12 ATE553129T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US7233398P	1998-01-23	1998-01-23

Publications (1)

Publication Number	Publication Date
ATE553129T1 true ATE553129T1 (de)	2012-04-15

Family

ID=22106938

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
AT07005606T ATE553129T1 (de)	1998-01-23	1999-01-15	Antikörper gegen humanes il-12
AT99904780T ATE357459T1 (de)	1998-01-23	1999-01-15	Antikörper gegen mensliches il-12

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
AT99904780T ATE357459T1 (de)	1998-01-23	1999-01-15	Antikörper gegen mensliches il-12

Country Status (18)

Country	Link
US (1)	US6225117B1 (de)
EP (2)	EP1049717B1 (de)
JP (3)	JP4481489B2 (de)
KR (1)	KR100764256B1 (de)
CN (2)	CN101274962A (de)
AR (2)	AR014459A1 (de)
AT (2)	ATE553129T1 (de)
AU (1)	AU759624B2 (de)
BR (1)	BR9907743A (de)
CA (1)	CA2318052C (de)
CY (2)	CY1106594T1 (de)
DE (1)	DE69935574T2 (de)
DK (2)	DK1049717T3 (de)
ES (2)	ES2284242T3 (de)
PT (2)	PT1049717E (de)
TR (1)	TR200002145T2 (de)
WO (1)	WO1999037682A2 (de)
ZA (1)	ZA99452B (de)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6399379B1 (en)	1992-09-29	2002-06-04	Isis Pharmaceuticals, Inc.	Antisense modulation of interleukin 12 p35 subunit expression
WO2003104495A1 (en) *	2002-06-11	2003-12-18	Isis Pharmaceuticals, Inc.	METHODS FOR BLOCKING ADIPOCYTE DIFFERENTIATION AND TRIGLYCERIDE ACCUMULATION WITH INTERLEUKIN 12 p35 INHIBITORS
US6706264B1 (en)	1994-03-14	2004-03-16	Genetics Institute, Llc	Use of IL-12 antagonists in the treatment of conditions promoted by an increase in levels of IFN-y
ZA95960B (en) *	1994-03-14	1995-10-10	Genetics Inst	Use of interleukin-12 antagonists in the treatment of autoimmune diseases
US7026456B1 (en) *	1998-01-23	2006-04-11	Hoffman-La Roche, Inc.	Antibodies against human IL-12
US6448081B1 (en)	2001-05-07	2002-09-10	Isis Pharmaceuticals, Inc.	Antisense modulation of interleukin 12 p40 subunit expression
DK1137766T3 (da) *	1998-12-09	2006-01-30	Protein Design Labs Inc	Anvendelse af IL-12-antistoffer til behandling af psoriasis
US6914128B1 (en)	1999-03-25	2005-07-05	Abbott Gmbh & Co. Kg	Human antibodies that bind human IL-12 and methods for producing
US7883704B2 (en)	1999-03-25	2011-02-08	Abbott Gmbh & Co. Kg	Methods for inhibiting the activity of the P40 subunit of human IL-12
US6939545B2 (en) *	1999-04-28	2005-09-06	Genetics Institute, Llc	Composition and method for treating inflammatory disorders
EP1259544B1 (de) *	2000-02-11	2011-08-24	Biogen Idec MA Inc.	Heterologes polypeptid der tnf familie
US6348316B1 (en)	2000-04-12	2002-02-19	Cedars-Sinai Medical Center	Genetic testing for determining the risk of pouchitis development
US6902734B2 (en)	2000-08-07	2005-06-07	Centocor, Inc.	Anti-IL-12 antibodies and compositions thereof
US7638604B2 (en) *	2001-02-23	2009-12-29	Genetics Institute, Llc	Monoclonal antibodies against interleukin-22
WO2002097048A2 (en) *	2001-05-30	2002-12-05	Centocor, Inc.	ANTI-p40 IMMUNOGLOBULIN DERIVED PROTEINS, COMPOSITIONS, METHODS AND USES
KR100453877B1 (ko) *	2001-07-26	2004-10-20	메덱스젠 주식회사	연쇄체화에 의한 면역 글로블린 융합 단백질의 제조 방법 및 이 방법에 의해 제조된 ＴＮＦＲ/Ｆｃ 융합 단백질, 상기 단백질을 코딩하는 ＤＮＡ, 상기 ＤＮＡ를 포함하는벡터, 및 상기 벡터에 의한 형질전환체
CA2512138C (en) *	2002-12-30	2013-07-16	Biogen Idec Ma Inc.	Kim-1 antagonists and use to modulate immune system
EP1711527A4 (de) *	2003-12-15	2008-09-03	Dendreon Corp	Hla-dr-spezifische antikörper, zusammensetzungen und verfahren
GB0329146D0 (en) *	2003-12-16	2004-01-21	Glaxosmithkline Biolog Sa	Vaccine
CA2591813A1 (en)	2004-12-21	2006-06-29	Centocor, Inc.	Anti-il-12 antibodies, epitopes, compositions, methods and uses
EP1865985B1 (de)	2005-03-02	2010-08-25	Biogen Idec MA Inc.	Kim-1-antikörper zur behandlung von th2-vermittelten erkrankungen
CN103145837A (zh) *	2005-06-30	2013-06-12	Abbvie公司	Il-12/p40结合蛋白
TWI417301B (zh)	2006-02-21	2013-12-01	Wyeth Corp	對抗人類介白素-２２（ｉｌ-２２）之抗體及其用途
TW200744634A (en) *	2006-02-21	2007-12-16	Wyeth Corp	Methods of using antibodies against human IL-22
WO2008088823A2 (en)	2007-01-16	2008-07-24	Abbott Laboratories	Methods for treating psoriasis
CA2681752A1 (en)	2007-03-29	2008-10-09	Abbott Laboratories	Crystalline anti-human 1l-12 antibodies
KR20100126515A (ko)	2008-03-18	2010-12-01	아보트 러보러터리즈	건선의 치료방법
MX2011001409A (es)	2008-08-14	2011-03-29	Cephalon Australia Pty Ltd	Anticuerpos anti-il-12/il-23.
MX2011005672A (es) *	2008-11-28	2011-06-20	Abbott Lab	Composiciones de anticuerpo estables y metodos para estabilizar a las mismas.
AU2010291927A1 (en) *	2009-09-14	2012-04-12	AbbVie Deutschland GmbH & Co. KG	Methods for treating psoriasis
CN103275222B (zh) *	2013-05-15	2014-04-16	中山康方生物医药有限公司	一种阻断白介素12 p40功能的单克隆抗体及其编码基因和应用
EP3436477A2 (de)	2016-03-29	2019-02-06	Janssen Biotech, Inc.	Verfahren zur behandlung von psoriasis mit erhöhter intervalldosierung von anti-il12- und/oder -23-antikörper
TW201922780A (zh) *	2017-09-25	2019-06-16	美商健生生物科技公司	以抗ｉｌ１２／ｉｌ２３抗體治療狼瘡之安全且有效之方法
WO2019220412A2 (en)	2018-05-18	2019-11-21	Janssen Biotech, Inc.	Safe and effective method of treating lupus with anti-il12/il23 antibody
HUE063462T2 (hu)	2018-09-24	2024-01-28	Janssen Biotech Inc	A colitis ulcerosa kezelésének biztonságos és hatékony eljárása anti-IL12/IL23 antitesttel
EP3972690A4 (de)	2019-05-23	2023-07-05	Janssen Biotech, Inc.	Verfahren zur behandlung einer entzündlichen darmerkrankung mit einer kombinationstherapie von antikörpern gegen il-23 und tnf-alpha
CA3183927A1 (en)	2020-05-21	2021-11-25	Janssen Biotech, Inc.	Method of treating inflammatory bowel disease with a combination therapy of antibodies to il-23 and tnf alpha

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5811523A (en)	1988-11-10	1998-09-22	Trinchieri; Giorgio	Antibodies to natural killer stimulatory factor
US5780597A (en)	1989-12-22	1998-07-14	Hoffmann-La Roche Inc.	Monoclonal antibodies to cytotoxic lymphocyte maturation factor
CA2125763C (en) *	1993-07-02	2007-08-28	Maurice Kent Gately	P40 homodimer of interleukin-12
US5536657A (en)	1993-07-19	1996-07-16	Hoffmann-La Roche Inc.	Recombinant DNA encoding human receptor for interleukin-12
ZA95960B (en) *	1994-03-14	1995-10-10	Genetics Inst	Use of interleukin-12 antagonists in the treatment of autoimmune diseases
US7119248B1 (en) *	1994-04-12	2006-10-10	Miltenyi Biotec Gmbh	Antibodies against epitopes with homology to self antigens, methods of preparation and applications thereof
US5853721A (en) *	1995-01-31	1998-12-29	Hoffmann-La Roche Inc.	Antibody to interleukin-12 receptor
US5853697A (en) *	1995-10-25	1998-12-29	The United States Of America, As Represented By The Department Of Health & Human Services	Methods of treating established colitis using antibodies against IL-12
US5809360A (en) *	1996-08-07	1998-09-15	Agfa Division - Bayer Corporation	Cassette for storing and accessing plates within an automated plate handler
AU734758B2 (en) *	1997-04-01	2001-06-21	Sankyo Company Limited	Anti-fas antibodies

1999
- 1999-01-15 KR KR1020007008036A patent/KR100764256B1/ko not_active Expired - Fee Related
- 1999-01-15 AT AT07005606T patent/ATE553129T1/de active
- 1999-01-15 DK DK99904780T patent/DK1049717T3/da active
- 1999-01-15 AU AU25177/99A patent/AU759624B2/en not_active Expired
- 1999-01-15 TR TR2000/02145T patent/TR200002145T2/xx unknown
- 1999-01-15 PT PT99904780T patent/PT1049717E/pt unknown
- 1999-01-15 WO PCT/EP1999/000202 patent/WO1999037682A2/en not_active Ceased
- 1999-01-15 EP EP99904780A patent/EP1049717B1/de not_active Expired - Lifetime
- 1999-01-15 DK DK07005606.4T patent/DK1818343T3/da active
- 1999-01-15 EP EP07005606A patent/EP1818343B1/de not_active Revoked
- 1999-01-15 CN CNA2008100016288A patent/CN101274962A/zh active Pending
- 1999-01-15 DE DE69935574T patent/DE69935574T2/de not_active Expired - Lifetime
- 1999-01-15 AT AT99904780T patent/ATE357459T1/de active
- 1999-01-15 ES ES99904780T patent/ES2284242T3/es not_active Expired - Lifetime
- 1999-01-15 BR BR9907743-4A patent/BR9907743A/pt not_active IP Right Cessation
- 1999-01-15 CA CA2318052A patent/CA2318052C/en not_active Expired - Lifetime
- 1999-01-15 JP JP2000528602A patent/JP4481489B2/ja not_active Expired - Fee Related
- 1999-01-15 CN CNB998023108A patent/CN100374466C/zh not_active Expired - Lifetime
- 1999-01-15 PT PT07005606T patent/PT1818343E/pt unknown
- 1999-01-15 ES ES07005606T patent/ES2386262T3/es not_active Expired - Lifetime
- 1999-01-19 US US09/232,522 patent/US6225117B1/en not_active Expired - Lifetime
- 1999-01-21 ZA ZA9900452A patent/ZA99452B/xx unknown
- 1999-01-22 AR ARP990100251A patent/AR014459A1/es active IP Right Grant
2007
- 2007-05-15 CY CY20071100657T patent/CY1106594T1/el unknown
- 2007-07-03 AR ARP070102968A patent/AR061801A2/es unknown
2009
- 2009-04-15 JP JP2009098976A patent/JP2009197008A/ja not_active Withdrawn
2012
- 2012-06-29 CY CY20121100589T patent/CY1112927T1/el unknown
2013
- 2013-02-19 JP JP2013029936A patent/JP2013139458A/ja active Pending

Also Published As

Publication number	Publication date
CN100374466C (zh)	2008-03-12
CY1106594T1 (el)	2012-01-25
AR014459A1 (es)	2001-02-28
EP1049717A2 (de)	2000-11-08
JP4481489B2 (ja)	2010-06-16
CN101274962A (zh)	2008-10-01
JP2002501085A (ja)	2002-01-15
DE69935574D1 (de)	2007-05-03
KR100764256B1 (ko)	2007-10-05
ATE357459T1 (de)	2007-04-15
CN1288468A (zh)	2001-03-21
JP2013139458A (ja)	2013-07-18
US6225117B1 (en)	2001-05-01
WO1999037682A3 (en)	1999-11-18
DE69935574T2 (de)	2007-12-06
EP1818343A3 (de)	2007-08-22
EP1818343A2 (de)	2007-08-15
CA2318052A1 (en)	1999-07-29
JP2009197008A (ja)	2009-09-03
TR200002145T2 (tr)	2000-11-21
ES2284242T3 (es)	2007-11-01
DK1818343T3 (da)	2012-07-16
EP1049717B1 (de)	2007-03-21
ES2386262T3 (es)	2012-08-14
EP1818343B1 (de)	2012-04-11
KR20010034315A (ko)	2001-04-25
ZA99452B (en)	1999-07-23
CY1112927T1 (el)	2016-04-13
BR9907743A (pt)	2000-10-17
PT1818343E (pt)	2012-07-12
WO1999037682A2 (en)	1999-07-29
PT1049717E (pt)	2007-05-31
AU2517799A (en)	1999-08-09
CA2318052C (en)	2012-07-03
DK1049717T3 (da)	2007-07-30
AU759624B2 (en)	2003-04-17
AR061801A2 (es)	2008-09-24

Publication	Publication Date	Title
ATE357459T1 (de)	2007-04-15	Antikörper gegen mensliches il-12
EE200000470A (et)	2001-12-17	Inimese CD40-vastased antikehad
ID22508A (id)	1999-10-28	Trokar untuk memasukkan implant-implant
NO20005488D0 (no)	2000-10-31	Hematopoetisk stimulering
NO20004758D0 (no)	2000-09-22	Vaksinesammensetning
DK1075512T3 (da)	2010-06-07	Cytotoxinbaseret biologisk indkapsling
DE69918109D1 (de)	2004-07-22	Haarwaschmittel
ID23076A (id)	2000-02-03	Popok sekali pakai
ID27841A (id)	2001-04-26	Turunan-turunan biaril terapeutik
NO20006191D0 (no)	2000-12-06	Vaksine
DE69931855D1 (de)	2006-07-27	Hautpräparat
LV12624B (lv)	2001-09-20	Tienilazolilalkosietanamini to iegusanas panemiens un pielietojums medikamentu legusana
NO20005599L (no)	2001-01-08	Vaksine
DE60044696D1 (de)	2010-09-02	Lippenstift
ID24759A (id)	2000-08-03	Metoda untuk meningkatkan volume tulang
ATE278712T1 (de)	2004-10-15	Antikörper gegen plazentaprotein 13
AR028262A1 (es)	2003-04-30	Anticuerpos especificos de fap-alfa humanos
ES1042932Y (es)	2000-03-16	Inyector-reactor biologico
KR980000095U (ko)	1998-03-30	벌꿀 채밀기
NO303697B1 (no)	1998-08-17	Innluftstenger
FI980767A7 (fi)	1999-10-04	Tutkimusspekula
FI3598U1 (fi)	1998-09-17	Paistokeppi
SE9904109D0 (sv)	1999-11-12	Kosmetisk beredning
FI3570U1 (fi)	1998-09-17	Verkkopuikkari
SE9901120D0 (sv)	1999-03-26	New human enzyme